[{"Assets_0_Q3_USD":77093000.0,"CommonStockSharesOutstanding_0_Q3_shares":8882785.0,"EarningsPerShareBasic_1_Q3_USD":-0.73,"EarningsPerShareBasic_3_Q3_USD":-2.6,"EarningsPerShareDiluted_1_Q3_USD":-0.73,"EarningsPerShareDiluted_3_Q3_USD":-2.6,"NetIncomeLoss_1_Q3_USD":-6511000.0,"NetIncomeLoss_3_Q3_USD":-19358000.0,"StockholdersEquity_0_Q3_USD":69120000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":8878430.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":7452709.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":8878430.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":7452709.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171114"}]